Kahn Brothers, managed by Alan Kahn and Thomas Kahn managed to beat the market in the first quarter of 2015, a period during which the fund’s co-founder and longtime manager...
Keep Reading →
April 13 - Hedge Funds, News
Hal Mintz's Sabby Capital has initiated a passive stake in Superconductor Technologies, Inc. (NASDAQ:SCON) according to a schedule 13G form filed with the SEC.
Keep Reading →
March 25 - Hedge Funds, News
Tracking the activity of hedge funds is a great way to identify profitable investments that will help you beat the market.
Keep Reading →
March 5 - Hedge Funds, News
Irving Kahn, the oldest active investor on Wall Street, died this week at age 109.
Keep Reading →
February 27 - Hedge Funds, News
In its latest 13F form filed with the U.S.
Keep Reading →
January 21 - Hedge Funds, News
Gilead Sciences, Inc. (NASDAQ:GILD), AbbVie Inc (NYSE:ABBV) and Merck & Co., Inc. (NYSE:MRK) have participated at the liver meeting in Boston, Massachusetts.
Keep Reading →
November 10 - News
Bristol-Myers Squibb Co (NYSE:BMY) along with Ono Pharmaceutical launched a lawsuit against Merck & Co., Inc.
Keep Reading →
September 9 - News
It must have been a bitter moment for President Barack Obama when he got the news that his favorite economic guru not only doesn’t like paying taxes but hates America.
Keep Reading →
August 29 - Hedge Funds
Ranjith Gopinathan, who is a program manager, life sciences and healthcare practice at Frost & Sullivan during an interview on CNBC said that while Merck & Co., Inc.
Keep Reading →
July 29 - News
CNBC's Meg Tirrell reported on the popular “Squawk Box” program that patients suffering from Alzheimer disease in U.S and across the globe are assuming epidemic proportions...
Keep Reading →
July 11 - News
Beech Hill Partners, led by Paul Cantor, Joseph Weiss, and Will Wurm, is a traditional boutique fund that was established as a privately owned investment advisory arm of Beech...
Keep Reading →
April 28 - Hedge Fund Analysis, Hedge Funds, News
Recent research conducted at InsiderMonkey has shown that stocks bought by insiders tend to outperform market indexes.
Keep Reading →
April 8 - Insider Trading, News
New York City-based Iguana Healthcare Management was founded by Stuart Weisbrod in 2010.
Keep Reading →
February 25 - Hedge Funds, News
Alex Denner’s Sarissa Capital disclosed its holdings in its latest and first 13F filings.
Keep Reading →
February 14 - Hedge Funds, News
Merck restructuring: On Tuesday, Merck & Co., Inc. (NYSE:MRK) announced that it will fire 8,500 workers.
Keep Reading →
October 2 - News
Innovation is everything when it comes to the pharmaceutical sector.
Keep Reading →
September 23 - News
The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.
Keep Reading →
September 17 - News
Through the years, London-based drugmaker AstraZeneca plc (ADR) (NYSE:AZN) and U.S. pharmaceutical firm Merck & Co., Inc.
Keep Reading →
September 17 - News
Heart disease is the leading cause of death in the United States. In 2010, according to data from the Centers for Disease Control and Prevention, 597,689 people in the U.S.
Keep Reading →
September 16 - News
AstraZeneca plc (ADR) (NYSE:AZN) may have missed out on acquiring the oncology platform of Onyx Pharmaceuticals, but it responded by pulling the trigger on a $500 million deal...
Keep Reading →
September 15 - News
There are few, if any, businesses in the world where innovation isn't the top priority.
Keep Reading →
September 14 - News
In an unusual divergence, stocks belonging to the defensive health care and cyclical technology spaces delivered some of the best responses to earnings last quarter .
Keep Reading →
September 12 - News
According to a recent Bloomberg report, Gilead Sciences, Inc.
Keep Reading →
September 11 - News
The Dogs of the Dow strategy involve investing equal amounts into the 10 highest-yielding dividend stocks on the Dow Jones Industrial Average 2 Minute (INDEXDJX:.DJI).
Keep Reading →
September 6 - News
At the moment, there are dozens of gauges investors can use to track Mr. Market. A pair of the most under-the-radar are hedge fund and insider trading movement.
Keep Reading →
September 6 - News
Peregrine Pharmaceuticals (NASDAQ:PPHM) will release its latest quarterly report on Monday, and investors are under no illusions that the company will avoid losing money again...
Keep Reading →
September 5 - News
In the financial world, there are many methods market participants can use to track the equity markets.
Keep Reading →
September 3 - News
Adding Esperion Therapeutics' ECT-1002 to Pfizer Inc. (NYSE:PFE)'s Lipitor lowered bad LDL cholesterol levels by 22%.
Keep Reading →
September 3 - News
Over the past couple of months we've discussed many of the biggest risk factors associated with some of the leading causes of death in the United States -- heart disease, cancer...
Keep Reading →
September 3 - News
ATLANTA (AP) -- When the HPV vaccine was first recommended for boys, health officials worried it would be an unusually hard sell.
Keep Reading →
August 30 - News
Now, according to many investors, hedge funds are seen as overrated, outdated investment tools of a period lost to current times.
Keep Reading →
August 30 - News
Top beef producer Tyson Foods, Inc. (NYSE:TSN) has decided to stop buying cattle that are fed the growth additive Zilmax, produced by Merck & Co., Inc. (NYSE:MRK).
Keep Reading →
August 29 - News
In an attempt to further simplify its business and unlock shareholder value, Pfizer Inc. (NYSE:PFE) has been busy divesting itself of non-core assets.
Keep Reading →
August 29 - News
In the 21st century investor’s toolkit, there are dozens of methods market participants can use to monitor the equity markets.
Keep Reading →
August 29 - News
One of the company's ushering in the next generation of hepatitis-C treatment is Gilead Sciences, Inc. (NASDAQ:GILD).
Keep Reading →
August 28 - News
Like a pebble rolling downhill and starting an avalanche, the decision by Tyson Foods, Inc.
Keep Reading →
August 28 - News
At the same time, the pharmaceutical industry isn't without its share of risks.
Keep Reading →
August 28 - News
Eli Lilly & Co. (NYSE:LLY) recently rose nearly 3% following positive phase 3 results for cancer drug necitumumab.
Keep Reading →
August 27 - News
We maintain a database of quarterly 13F filings from hundreds of hedge funds and other notable investors.
Keep Reading →
August 27 - Hedge Funds
The Dow Jones Industrial Average (INDEXDJX:.DJI) has 30 components, and all but one can trace their origins to a company founded in the United States after the American Revolution...
Keep Reading →
August 26 - News
HIV, the virus that causes AIDS, has become one of the world's most devastating diseases since it was first recognized more than three decades ago.
Keep Reading →
August 23 - News
The Medicines Company (NASDAQ:MDCO) is a mid-cap value stock that jumped by 21% in the last 12 months, trading at a 52-week price range of $20.04-$37.40.
Keep Reading →
August 23 - News
To the average investor, there are plenty of gauges investors can use to track Mr. Market. Some of the most useful are hedge fund and insider trading interest.
Keep Reading →
August 22 - News
In the eyes of many of your peers, hedge funds are perceived as useless, outdated financial tools of a forgotten age.
Keep Reading →
August 22 - News
Now, according to many traders, hedge funds are seen as delayed, outdated investment tools of an era lost to time.
Keep Reading →
August 21 - News
If you've ever taken the time to really follow the biopharmaceutical sector, you know very well that failures are a dime a dozen, and success stories are few and far between.
Keep Reading →
August 19 - News
At least the Food and Drug Administration is polite.
Keep Reading →
August 19 - News
